(Total Views: 761)
Posted On: 09/17/2020 9:46:38 PM
Post# of 153977
The article states what we all know:
Trauger, CytoDyn’s former chief science officer, said he hopes the drug can eventually help people.
“But where that will be and when that will be is up to the company and the veracity and rigor they bring it forward with,” Trauger said. “We can talk about personalities all day long. In the end, the science dictates everything.”
Read More: https://investorshangout.com/post/view?id=589...z6YM0RnzMY
Trauger, CytoDyn’s former chief science officer, said he hopes the drug can eventually help people.
“But where that will be and when that will be is up to the company and the veracity and rigor they bring it forward with,” Trauger said. “We can talk about personalities all day long. In the end, the science dictates everything.”
Read More: https://investorshangout.com/post/view?id=589...z6YM0RnzMY
(6)
(0)
